Site navigation

Navigation

Hepatitis B (chronic) - adefovir dipivoxil and pegylated interferon alpha-2a

Adefovir dipivoxil and peginterferon alfa-2a for the treatment of chronic hepatitis B

Summary

NICE has made the following recommendations about the use of adefovir dipivoxil and peginterferon alfa-2a to treat chronic hepatitis B. These recommendations do not apply to people who are also infected with hepatitis C or D, or HIV. Peginterferon alfa-2a is recommended as a possible first treatme ...

Read the complete summary


Guidance documents

Implementing this guidance

Other information

We will consult on our review plans for this guidance in February 2009

About this guidance

Technology appraisals TA96

Issued: February 2006

How this guidance was produced

See also:

See this guidance in practice:

Order printed copies of this guidance